IT vs XERS · P/E 16, rev $3.19B vs rev $175.2M
Gartner Inc (IT) versus Xeris Pharmaceuticals Inc (XERS) — a side-by-side from cached financials, not a winner call.
Gartner Inc (IT) is a information technology services company listed on US.
Xeris Pharmaceuticals Inc (XERS) is a biotechnology company listed on US.
Latest reported IT revenue for 2026-06-30 was $3.19B. Net income was $497.8M. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Latest reported XERS revenue for 2026-06-30 was $175.2M. Net income was -$28.9M. XERS currently screens at market cap $760.7M.
IT currently screens at market cap $11.03B and trailing P/E 16.3. XERS currently screens at market cap $760.7M.
Not investment advice. Open the IT and XERS stock pages for the full models.
Not investment advice.